These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 9168850)

  • 41. Cost effectiveness of fluticasone and budesonide in patients with moderate asthma.
    Steinmetz KO; Volmer T; Trautmann M; Kielhorn A
    Clin Drug Investig; 1998; 16(2):117-23. PubMed ID: 18370529
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Health-related quality of life associated with chronic conditions in eight countries: results from the International Quality of Life Assessment (IQOLA) Project.
    Alonso J; Ferrer M; Gandek B; Ware JE; Aaronson NK; Mosconi P; Rasmussen NK; Bullinger M; Fukuhara S; Kaasa S; Leplège A;
    Qual Life Res; 2004 Mar; 13(2):283-98. PubMed ID: 15085901
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Management of asthma in adults: current therapy and future directions.
    Green RH; Brightling CE; Pavord ID; Wardlaw AJ
    Postgrad Med J; 2003 May; 79(931):259-67. PubMed ID: 12782771
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Measuring health-related quality of life in patients with chronic obstructive pulmonary disease in a routine hospital setting: feasibility and perceived value.
    Bendtsen P; Leijon M; Sofie Sommer A; Kristenson M
    Health Qual Life Outcomes; 2003 Apr; 1():5. PubMed ID: 12740035
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhaled fluticasone propionate. A pharmacoeconomic review of its use in the management of asthma.
    Lamb HM; Culy CR; Faulds D
    Pharmacoeconomics; 2000 Nov; 18(5):487-510. PubMed ID: 11151402
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cost implications for the use of inhaled anti-inflammatory medications in the treatment of asthma.
    Ozminkowski RJ; Wang S; Marder WD; Azzolini J; Schutt D
    Pharmacoeconomics; 2000 Sep; 18(3):253-64. PubMed ID: 11147392
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of depressive symptoms on health-related quality of life in asthma patients.
    Mancuso CA; Peterson MG; Charlson ME
    J Gen Intern Med; 2000 May; 15(5):301-10. PubMed ID: 10840265
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Beclomethasone for asthma in children: effects on linear growth.
    Sharek PJ; Bergman DA
    Cochrane Database Syst Rev; 2000; 1999(2):CD001282. PubMed ID: 10796632
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cost effectiveness of fluticasone propionate and flunisolide in the treatment of corticosteroid-naive patients with moderate asthma.
    Volmer T; Kielhorn A; Weber HH; Wiessmann KJ
    Pharmacoeconomics; 1999 Nov; 16(5 Pt 2):525-31. PubMed ID: 10662477
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhaled fluticasone propionate: a review of its therapeutic efficacy at dosages < or = 500 microg/day in adults and adolescents with mild to moderate asthma.
    Jarvis B; Faulds D
    Drugs; 1999 May; 57(5):769-803. PubMed ID: 10353302
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of fluticasone propionate powder on health-related quality of life in patients with moderate asthma.
    Mahajan P; Okamoto LJ; Schaberg A; Kellerman D; Schoenwetter WF
    J Asthma; 1997; 34(3):227-34. PubMed ID: 9168850
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fluticasone propionate improves quality of life in patients with asthma requiring oral corticosteroids.
    Okamoto LJ; Noonan M; DeBoisblanc BP; Kellerman DJ
    Ann Allergy Asthma Immunol; 1996 May; 76(5):455-61. PubMed ID: 8630720
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A 12-week dose-ranging study of fluticasone propionate powder in the treatment of asthma.
    Wasserman SI; Gross GN; Schoenwetter WF; Munk ZM; Kral KM; Schaberg A; Kellerman DJ
    J Asthma; 1996; 33(4):265-74. PubMed ID: 8707781
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative efficacy and safety of twice daily fluticasone propionate powder versus placebo in the treatment of moderate asthma.
    Pearlman DS; Noonan MJ; Tashkin DP; Goldstein MF; Hamedani AG; Kellerman DJ; Schaberg A
    Ann Allergy Asthma Immunol; 1997 Apr; 78(4):356-62. PubMed ID: 9109702
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dose-related response to inhaled fluticasone propionate in patients with methacholine-induced bronchial hyperresponsiveness: a double-blind, placebo-controlled study.
    Noonan MJ; Chervinsky P; Wolfe J; Liddle R; Kellerman DJ; Crescenzi KL
    J Asthma; 1998; 35(2):153-64. PubMed ID: 9576141
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.